Netherlands· NL-fe183d65bc0e

Pomalidomide Synthon 2 mg, harde capsules

A pomalidomide product containing pomalidomide, registered in Netherlands by Synthon B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L04AX06

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pomalidomideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pomalidomide is registered in 17 of 19 countries.

Countries holding a registration under ATC L04AX06 (pomalidomide), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search pomalidomide products by name

Pomalidomide · ATC L04AX06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pomalidomide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Pomalidomide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

CH Switzerland$255.48

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: POMALIDOMIDE
Manufacturer: Synthon B.V.
Country: Netherlands (NL)
ATC code: L04AX06
ATC class: Pomalidomide
Defined daily dose: 3 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
132079

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

277 interactions on record for pomalidomide.

Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pomalidomide against other medicines How interaction checks work

Pomalidomide · interactions on record

277 records

64 severe
213 moderate

Most severe, free to view

ErythropoietinB03XA01severe
Darbepoetin alfaB03XA02severe
PeginesatideB03XA04severe
C1-inhibitor, plasma derivedB06AC01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pomalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pomalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Pomalidomid +pharma, Pomalidomid Devatis
Belgium · Pomalidomide Eg, Pomalidomide Eugia
Bulgaria · Помалидомид Devatis, Помалидомид Булгермед
Cyprus · Pomalidomide, Pomalidomide Adalvo
Czechia · Pomalidomid Sanexcel, Pomalidomide Abdi
Germany · Pomadel, Pomalidomid 123 Acurae Pharma
Denmark · Pomalidomid Devatis, Pomalidomid Grindeks
Estonia · Pomalidomide Grindeks, Pomalidomide Olpha
Spain · Pomalidomida Abdi, Pomalidomida Erawya
Finland · Pomalidomid Avansor, Pomalidomid Devatis
France · Pomalidomide Eg, Pomalidomide Eugia
United Kingdom (Northern Ireland) · Pomalidomide, Pomalidomide Amarox
Greece · Polidma, Pomalidomide Anabiosis
Hungary · Pomalidomid Onkogen, Pomalidomide Grindeks
Ireland · Pomalidomide Clonmel, Pomalidomide Grindeks
Iceland · Imnovid, Pomalidomide Accord
Italy · Pomalidomide Abdi, Pomalidomide Aurobindo
Liechtenstein · Imnovid, Pomalidomide Accord
Lithuania · Pomalidomide Grindeks, Pomalidomide Olpha
Luxembourg · Pomalidomide Eg, Pomalidomide Eugia
Latvia · Pomalidomide Grindeks, Pomalidomide Olpha
Malta · Pomalidomide, Pomalidomide Clonmel
Norway · Imnovid, Pomalidomid Devatis
Poland · Pomalidomid Reig Jofre, Pomalidomide Eugia
Portugal · Pomalidomida Aurobindo, Pomalidomida Bluepharma
Romania · Pomalidomidă Dr. Reddy’s, Pomalidomidă Grindeks
Sweden · Davunfite, Pomalidomid Avansor
Slovenia · Pomadel, Pomalidomid Grindeks
Slovakia · Pomalidomid Grindeks, Pomalidomid Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fd58076e-01d2-4ae7-a7f7-985671e76f82
GET /v1/drugs/fd58076e-01d2-4ae7-a7f7-985671e76f82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132079_smpc.pdf",
  "strength": null,
  "atc_label": "Pomalidomide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132079",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "MALTODEXTRINE",
    "NATRIUMSTEARYLFUMARAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)",
    "WITTE INKT"
  ],
  "substances": [
    "POMALIDOMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132079.pdf",
  "authorised_at": "2024/06/28",
  "procedure_number": "NL/H/5831/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132079",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about pomalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console